Navigation Links
New breast imaging algorithm brings breast cancer diagnosis and treatment to underserved area of Uganda
Date:4/12/2013

Radiologists are a step closer to implementing a program in an underserved region of Uganda for diagnosing and treating women with palpable breast masses.

The program combines a unique diagnostic algorithm along with targeted community outreach, said medical student Chris Duncan working with the organization Imaging the World. Imaging the World, a non-profit organization dedicated to bringing diagnostic imaging to underserved areas around the world, has multiple obstetrical imaging programs currently operating in Uganda and plans to expand both the obstetric imaging and breast imaging programs.

"We just returned from a trip to Kamuli, Uganda where we laid the groundwork for implementation of the diagnostic algorithm," said Mr. Duncan, a fourth year medical student at University of Vermont. "Our team met with local stakeholders, determined available treatments and identified potential barriers," he said. "The meetings helped ensure that we can create appropriate local resources prior to our program roll-out this summer," he said.

The diagnostic algorithm is designed to be simpler and more effective than the current course of breast cancer diagnosis and treatment for women in Uganda, a region where most breast cancer patients are diagnosed with late stage breast cancer, said Mr. Duncan.

The algorithm focuses on breast ultrasound as an initial diagnostic tool for evaluating palpable breast masses. The breast ultrasound exam is done by minimally trained personnel who follow a standardized scanning methodology. The ultrasound images are then compressed, uploaded to a server through a cellular network, and interpreted at another location by an imaging expert. (Research continues in the U.S. to evaluate the quality of the images obtained using the algorithm, with preliminary results suggesting that the images are more than adequate for evaluating breast masses, said Mr. Duncan)

After the images are interpreted, the results are sent back to the clinic where the ultrasound was performed. If the results indicate the need for a biopsy, the patient is referred to the district referral hospital. "We have trained local surgeons to perform both fine-needle and core biopsies using ultrasound guidance," said Mr. Duncan. If the biopsy is positive for cancer, the patient is referred to the major tertiary referral hospital in the capital city for treatment. "We are hiring a patient care navigator to assist women in the complicated and daunting process of receiving breast cancer care," said Mr. Duncan. "We are also working on obtaining funding for a lodging area where the women can stay during their treatment period in the capital city," he said.

The recent trip also emphasized the need for patient education. There are some in the community that believe that cancer is contagious, that surgery spreads cancer throughout the body or that cancer is due to curses, evil spirits and various other supernatural etiologies. "We hope that our education campaign will help to eradicate these myths, opening the path to early diagnosis and effective care for these women," said Mr. Duncan.

The Uganda breast imaging program is being described in an electronic exhibit featured at the ARRS Annual Meeting in Washington, DC.


'/>"/>

Contact: Samantha Schmidt
sschmidt@arrs.org
703-858-4316
American Roentgen Ray Society
Source:Eurekalert

Related medicine news :

1. Menopause-Like Woes Hinder Breast Cancer Treatment: Study
2. Estrogen Level in Pregnancy May Affect Breast Cancer Risk in Daughters
3. 25 percent dont complete recommended breast cancer treatment
4. Omega-3 fatty acids more effective at inhibiting growth of triple-negative breast cancer
5. For breast cancer screening, 1 size doesnt fit all
6. For Older Women, Missed Mammograms Tied to Worse Breast Cancer Outcomes
7. Breast Cancer Death Rates Higher for Black Women: Study
8. Teen Boys With Enlarged Breasts Show Emotional Effects
9. Moffitt Cancer Center researchers discuss new frontiers in breast cancer screening
10. Breast Cancer Gene Tests Wont Help Most Women: Report
11. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: